MediWound's EscharEx Phase III VALUE Study To Continue Without Modification Following DSMB Review

MediWound said an independent Data and Safety Monitoring Board completed its scheduled safety review of the Phase III VALUE trial of EscharEx for venous leg ulcers. The DSMB's recommendation, as indicated by the article, is supportive of continued trial progress, reducing a near-term clinical safety risk for the program.